Study withdrawn: researchers planned to track blood sugar in pregnancy
NCT ID NCT06490874
Summary
This study aimed to gather detailed blood sugar data from pregnant people with gestational diabetes who needed medication. It planned to compare glucose patterns between those taking metformin pills and those using insulin injections. The goal was to see if one medication led to better blood sugar control and to learn if continuous glucose monitors could help predict health problems for the mother or baby. However, this specific study was withdrawn and did not enroll any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY, HIGH RISK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Premier Health - Miami Valley Hospital
Dayton, Ohio, 45409, United States
-
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, 43210, United States
-
University of Alabama
Tuscaloosa, Alabama, 35487, United States
Conditions
Explore the condition pages connected to this study.